Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Normal values for female external genitalia size at birth, particularly clitoris and blood level of androgens are not well known. This study's aim is to collect normal values in 180 newborn girls of 24 to 41 weeks of pregnancy, and to build genitalia growth charts according to gestational age and birth weight.
The investigators will measure clitoris, genito-anal ratio using a small plastic caliper, at birth, and their evolution until Day 3 of life (if the child is still at the hospital).
The investigators also want to establish normal values of blood testosterone, 17-hydroxyprogesterone, delta4-androstenedione, 21-deoxycortisol, 11-deoxycortisol, deoxycorticosterone, corticosterone, dehydroepiandrostenedione, and dihydrotestosterone), using samples taken for systematic post natal screening of diseases (only in new born of 35 or more weeks of birth).
This is an observational prospective study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy female newborns | Healthy female newborns 24 to 41 weeks of pregnancy without sexual development disturbances |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| External genitalia measurements in female newborns | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| length of the clitoris | The measurement is performed on the supine child, with flexed hips and knees retained by the nurse or the nursery nurse. The clitoris will be delimited using cavernosa palpation. The clitoris length will be measured from maxima lablias'root to the top of clitoris, excluding cutaneous cover. Measurements are performed using an-8 cm plastic caliper. | Day 1 |
| length of the clitoris | The measurement is performed on the supine child, with flexed hips and knees retained by the nurse or the nursery nurse. The clitoris will be delimited using cavernosa palpation. The clitoris length will be measured from maxima lablias'root to the top of clitoris, excluding cutaneous cover. Measurements are performed using an-8 cm plastic caliper | Day 3 |
| Measure | Description | Time Frame |
|---|---|---|
| clitoris width | The clitoris will be measured at its base, using an-8 cm plastic caliper. | Day 1 |
| clitoris width | Measurement will be done if newborns stay at the hospital |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Female newborns, with gestational ages of 24 to 41 weeks of pregnancy.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Claire-Lise GAY, MD | Contact | 472 129 531 | +33 | claire-lise.gay@chu-lyon.fr |
| Cornu Catherine, MD | Contact | 472 357 231 | +33 | catherine.cornu@chu-lyon.fr |
| Name | Affiliation | Role |
|---|---|---|
| Claire-Lise GAY, MD | Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital Femme Mere Enfant | Recruiting | Bron | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Day 3 |
| anogenital ratio | The ano-genital ratio is the ratio between 1) the distance from anus center to the base of clitoris and 2) the distance from anus center and the posterior commissure of the vulva frenulum. | Day 1 |
| anogenital ratio | Measurement will be done if newborns stay at the hospital | Day 3 |
| Blood level of testosterone | This dosage will be performed using a 1.5 ml blood sample taken for screening purpose (for routine systematic post natal screening) only in newborn over 35 WA | Day 3 |
| Blood level of 17-hydroxyprogesterone | This dosage will be performed using a 1.5 ml blood sample taken for screening purpose (for routine systematic post natal screening) only in newborn over 35 WA | Day 3 |
| Blood level of delta4-androstenedione | This dosage will be performed using a 1.5 ml blood sample taken for screening purpose (for routine systematic post natal screening) only in newborn over 35 WA | Day 3 |
| Blood level of 21-deoxycortisol | This dosage will be performed using a 1.5 ml blood sample taken for screening purpose (for routine systematic post natal screening) only in newborn over 35 WA | Day 3 |
| Blood level of corticosterone | This dosage will be performed using a 1.5 ml blood sample taken for screening purpose (for routine systematic post natal screening) only in newborn over 35 WA | Day 3 |
| Blood level of dihydrotestosterone | This dosage will be performed using a 1.5 ml blood sample taken for screening purpose (for routine systematic post natal screening) only in newborn over 35 WA | Day 3 |